Yayın:
Infection Medications: Assessment In‐Vitro Glutathione S‐Transferase Inhibition and Molecular Docking Study

dc.contributor.authorBEYDEMİR, ŞÜKRÜ
dc.contributor.authorYeliz Demir
dc.contributor.authorŞükrü Beydemir
dc.contributor.orcid0000-0002-2932-2789
dc.contributor.orcid0000-0003-3216-1098
dc.contributor.orcid0000-0003-3667-6902
dc.date.accessioned2025-11-13T09:09:45Z
dc.date.issued2021-11-16
dc.identifier.doihttps://doi.org/10.1002/slct.202103197
dc.identifier.endpage11924
dc.identifier.issn2365-6549
dc.identifier.issue43
dc.identifier.openalexW3213353830
dc.identifier.startpage11915
dc.identifier.urihttps://hdl.handle.net/11421/636
dc.identifier.urihttps://doi.org/10.1002/slct.202103197
dc.identifier.volume6
dc.language.isoen
dc.relation.ispartofChemistrySelect
dc.rightsrestrictedAccess
dc.subjectPharmacology
dc.subjectGanciclovir
dc.subjectIn vitro
dc.subjectChemistry
dc.subjectCaspofungin
dc.subjectAmphotericin B
dc.subjectBiology
dc.subjectBiochemistry
dc.subjectMicrobiology
dc.subjectHuman cytomegalovirus
dc.subjectAntifungal
dc.subject.sdg3
dc.titleInfection Medications: Assessment In‐Vitro Glutathione S‐Transferase Inhibition and Molecular Docking Study
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5081967794

Dosyalar

Koleksiyonlar